Nathan A. Berger, dean of the School of Medicine and vice president for medical affairs, said, "This is truly an honor for Dr. Warman, the Department of Genetics, and the CWRU School of Medicine. Receiving an appointment from the Howard Hughes Medical Institute is tremendous recognition for the scientist and his work."
Earlier this spring Warman was selected as one of 10 U.S. researchers to receive the Burroughs Wellcome Fund Clinical Scientist Award in Translational Research. The award, worth $750,000 over five years, is one of Burroughs Wellcome's largest and most prestigious awards. The award will begin July 1. He will use the funds to support his research in arthritis, specifically to delineate the proteins and pathways that maintain human joints and their potential for treating heritable and acquired forms of the disease.
This is the second year in a row that a CWRU researcher has received this award. Last year, Dennis Templeton, associate professor of pathology, was one of nine researchers in the United States to receive it for his studies in colon cancer.
The Clinical Scientist Awards are intended to foster the development and productivity of mid-career physician-scientists who will strengthen translational research, the two-way transfer between basic science research and the treatment of patients, through their own studies as well as their mentoring of the next generation of physician investigators.
The Burroughs Wellcome Fund, located in Research Triangle Park, North Carolina, is an independent, private foundation dedicated to advancing the medical sciences by supporting research and other scientific and educational activities. The fund's current assets are in excess of $700 million and annual grants are approximately $47 million.
'"/>
Contact: George Stamatis
gxs18@po.cwru.edu
216-368-3635
Case Western Reserve University
22-May-2000